Telmisartan Research Overview
Telmisartan is an angiotensin II receptor blocker (ARB) that selectively antagonises AT1 receptors, providing researchers with a pharmaceutical-grade reference standard for cardiovascular and metabolic investigations. This Neutec-manufactured compound enables scientists to study ARB mechanisms, receptor binding kinetics, and downstream signalling pathways in controlled laboratory environments. Our Stroid UK Shop maintains rigorous quality standards for all pharmaceutical reference materials, ensuring consistent results in experimental protocols.
Laboratory Research Applications
Research teams utilise telmisartan to investigate angiotensin II receptor pharmacology, particularly AT1 receptor selectivity and binding affinity studies. The compound serves as a valuable tool for examining renin-angiotensin system modulation in cell culture models and tissue preparations. Cardiovascular researchers study its effects on vascular smooth muscle cells, while metabolic researchers investigate PPAR-gamma agonist properties in adipocyte cultures. Scientists exploring telmisartan research compounds benefit from this pharmaceutical reference standard’s well-characterised pharmacological profile. Additionally, researchers studying combination therapies often compare telmisartan with SARM compounds and peptide modulators to understand synergistic mechanisms in metabolic regulation studies.
Product Specifications
| Parameter | Value |
|---|---|
| Active Compound | Telmisartan |
| Strength | 80mg per unit |
| Manufacturer | Neutec |
| CAS Number | 144701-48-4 |
| Molecular Formula | C₃₃H₃₀N₄O₂ |
| Molecular Weight | 514.62 g/mol |
| Storage | Room temperature, dry conditions |
Research Compliance Statement
Telvis 80 Neutec is manufactured exclusively for in-vitro laboratory research applications and scientific studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with institutional guidelines, maintain appropriate laboratory safety protocols, and ensure proper waste disposal procedures when handling this pharmaceutical reference standard. All studies should be conducted under appropriate ethical oversight and regulatory compliance frameworks applicable to the research jurisdiction.
